The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Pacific Biosciences of California Inc’s stock clocked out at $1.32, down -2.94% from its previous closing price of $1.36. In other words, the price has decreased by -$2.94 from its previous closing price. On the day, 4.8 million shares were traded.
Ratios:
To gain a deeper understanding of PACB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.59 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.31.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when HENRY CHRISTIAN O sold 12,497 shares for $1.41 per share. The transaction valued at 17,583 led to the insider holds 2,225,357 shares of the business.
Van Oene Mark sold 6,486 shares of PACB for $9,126 on Mar 03 ’25. The insider now owns 1,497,695 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Farmer Michele, who serves as the insider of the company, sold 2,973 shares for $1.41 each. As a result, the insider received 4,183 and left with 184,619 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.55 while its Price-to-Book (P/B) ratio in mrq is 0.77.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $3.35, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -4.66%, while the 200-Day Moving Average is calculated to be -21.81%.
Shares Statistics:
A total of 294.42M shares are outstanding, with a floating share count of 262.18M. Insiders hold about 11.98% of the company’s shares, while institutions hold 72.77% stake in the company.
